VistaGen Therapeutics
VTGN
$4.55
Share price
-1.52%
Change (1 day)
3,400.00%
Change (1 year)
Categories
P/S ratio for VistaGen Therapeutics (VTGN)
P/S ratio as of May 2024 (TTM): 120
According to VistaGen Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 119.789. At the end of 2023 the company had a P/S ratio of 133.
P/S ratio history for VistaGen Therapeutics from 2011 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 133 | |
| 2022 | N/A | -100% |
| 2021 | 258 | -37.31% |
| 2020 | 411 | |
| 2019 | N/A | |
| 2018 | N/A | -100% |
| 2017 | 19.5 | -22.17% |
| 2016 | 25.0 | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | 21.1 | -62.4% |
| 2011 | 56.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |